DYN Stock Price
Dyne Therapeutics, Inc.
DYN stock price is $17.99 (+0.39% on the day), giving Dyne Therapeutics, Inc. a market cap of $3.37B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
DYN Stock Overview
- Price
- $17.99
- Previous close
- $17.92
- Open
- $18.10
- Market cap
- $3.37B
- 52-week range
- $14.00 - $27.30
- 1-year price target
- $34.60
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 55
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DYN | $17.99 | +0.4% | 1.91M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |